PLx Pharma: Clinical Trials

11 trials sponsored by PLx Pharma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed. 5 Phase 1, 5 Phase 2, 2 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 15Completed 5
Phase 25Completed 5
Phase 32Completed 2
Phase 41Completed 1

Follow PLx Pharma: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacodynamic and Pharmacokinetic Study of PL-ASA
PL-ASA - Healthy Volunteers
Phase 4CompletedPLx Pharma362021-04-282022-04-25
Randomized, Crossover Bioequivalence Study of PL-ASA Versus Immediate Release Aspirin in Healthy Volunteers.
Pharmaceutical-lipid aspirin (PL-ASA) - Bioequivalence
Phase 1CompletedPLx Pharma242020-05-072022-04-27
Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated Aspirin in Diabetic Patients
PL2200 Aspirin Capsules, Enteric-coated aspirin caplets - Diabetes Mellitus, Type 2
Phase 3CompletedPLx Pharma572014-01-012016-03-10
Evaluation of Upper GI Ulceration Induced by PL2200 Versus Aspirin in At-Risk Subjects
PL2200, Aspirin tablets - Gastroduodenal Ulceration
Phase 2CompletedPLx Pharma2472012-09-012022-06-07
Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate Release Aspirin in Diabetic Patients
PL2200 Aspirin Capsules, Immediate-Release Aspirin Tablets, Enteric-coated aspirin caplets - Diabetes Mellitus, Type 2
Phase 3CompletedPLx Pharma402012-01-012016-03-14
Food-Effect Pharmacokinetic Study of PL2200
PL2200 fasted, PL2200 fed - Healthy
Phase 1CompletedPLx Pharma202010-10-012010-12-13
Clinical Trial Evaluating Gastrointestinal Damage Following Administration PL3100 or Naproxen in At-Risk Adults
PL3100, Naproxen - Gastroduodenal Ulcerations, Erosion
Phase 2CompletedPLx Pharma772010-07-012016-04-11
Oral Bioequivalence Study of PL 3100 and Naproxen in Healthy Adults
Naproxen, PL 3100 - Healthy Volunteers
Phase 1 / Phase 2CompletedPLx Pharma342009-08-012015-09-07
Endoscopic Evaluation of Upper Gastrointestinal (GI) Mucosal Damage Induced by PL-2200 Versus Aspirin in Healthy Volunteers
acetylsalicylic acid - Upper Gastrointestinal Mucosal Damage
Phase 1 / Phase 2CompletedPLx Pharma2042009-01-012015-08-11
Pharmacokinetic and Pharmacodynamic Assessment of a Novel, Pharmaceutical Lipid-Aspirin Complex
Aspirin - Bioequivalence
Phase 1CompletedPLx Pharma322008-02-112019-07-05
Ibuprofen-PC Compared With Ibuprofen in a GI Safety Trial
Ibuprofen-PC - Osteoarthritis
Phase 2CompletedPLx Pharma1252005-01-012008-11-26

Conditions studied

Diabetes Mellitus, Type 2 (2)  ·  Osteoarthritis (1)

Interventions

Aspirin (3)  ·  Naproxen (2)  ·  aspirin-phosphatidylcholine (1)

Countries

United States (9)

Top investigators

Alan J Kivitz, MD (1)  ·  Byron L Cryer, MD (1)  ·  Francesco Franchi, MD (1)  ·  Frank L Lanza, MD (1)  ·  Howard Schwartz, MD (1)  ·  Michael E Schwartz, DO (1)  ·  Phillip B Miner, MD (1)  ·  Upendra K Marathi, PhD (1)  ·  Upendra K. Marathi, PhD (1)  ·  Upendra Marathi, PhD (1)

Results publications

PMID 28089180, PMID 31420787, PMID 32080811, PMID 36036856

NIH funding

1RC3AR059535-01 (1)